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PURPOSE: Inspite of the long experience with the treatment of intermittent claudication, little is known about the
natural history of stenotic lesions in the iliac segment. With the advent of endovascular treatment, this knowledge has
become important.
METHODS: Fifty-two stenosis, diagnosed using arteriography, in 38 claudicant patients were analyzed. After a minimum
time interval of 6 months, a magnetic resonance angiography was performed to determine whether there was arterial
occlusion.
The primary factors that could influence the progression of a stenosis were analyzed, such as risk factors (smoking,
hypertension, diabetes, sex, and age), compliance with clinical treatment, initial degree of stenosis, site of the stenosis, and
length of follow-up.
RESULTS: The average length of follow-up was 39 months. From the 52 lesions analyzed, 13 (25%) evolved to
occlusion. When occlusion occurred, there was clinical deterioration in 63.2% of cases. This association was statistically
significant (P = .002). There was no statistically significant association of the progression of the lesion with the degree or
site of stenosis, compliance with treatment, or length of follow-up. Patients who evolved to occlusion were younger (P =
.02). The logistic regression model showed that the determinant factors for clinical deterioration were arterial occlusion and
noncompliance with clinical treatment.
CONCLUSIONS: The progression of a stenosis to occlusion, which occurred in 25% of the cases, caused clinical
deterioration. Clinical treatment was important, but it did not forestall the arterial occlusion. Prevention of occlusion could
be achieved by early endovascular intervention or with the development of drugs that might stabilize the atherosclerotic
plaque.
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Atherosclerosis is an inflammatory
disease with a slow evolution. It begins
with thickening of the arterial wall,
causing stenosis of the vessel lumen
and, finally, arterial occlusion.1 How-
ever, accidents may occur in the
atherosclerotic plaque, such as small
ulcerations or ruptures that accelerate
the occlusive process in an unpredict-
able way.2,3
In the lower limbs, intermittent
claudication (IC) is the initial symp-
tom of obstructive atherosclerosis. The
great majority of patients with IC
treated clinically respond satisfacto-
rily.4-7 When patients do not improve,
there may be an indication for
endovascular treatment if this is ana-
tomically possible, especially for the
aorto-iliac segment.8-10 Doubts still ex-
ist regarding the best therapeutic op-
tion over the long term.11-14
Despite wide experience with the
treatment of IC, little is known about
the natural evolution of stenotic le-
sions in the iliac segment. In the past,
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not much attention was given to more
detailed studies of arterial stenosis in
the lower limbs, since surgical treat-
ment did not depend on the type of le-
sion (ie, occlusion or stenosis).
With the advent of endovascular
treatment, knowledge of the natural
history of stenosis became important,
and some authors have been perform-
ing this type of study, especially in the
superficial femoral artery.15 However,
stenosis in the iliac arteries have not
yet been studied, and this is exactly
where endovascular treatment is most
often performed and gives the best re-
sults.16
The goal of this study was to de-
termine the natural evolution of steno-
sis in the iliac arteries and to compare
this with the clinical evolution of pa-
tients.
METHODS
From January 1993 to December
2001, 1380 patients with intermittent
claudication (IC) were admitted at our
division. It is not our routine to pre-
scribe an arteriography (AG) for pa-
tients with IC,17 but some patients are
referred to us from other specialists and
come with an arteriograph. From the
patients with IC who had an arteriog-
raphy, there were 38 with stenosis in
iliac arteries. These 38 patients were
prospectively surveyed.
This was a prospective,
nonrandomized, and uncontrolled
study. All patients underwent similar
treatment, following the same protocol,
in accordance with the ethical stand-
ards of the Committee of Ethics for
Analysis of Research Projects on Hu-
man Experimentation and with the
Helsinki Declaration of 1975, as re-
vised in 1983.
The average age was 63 years
(ranging from 41 to 78 years); 21%
were female and 79% male. The pri-
mary risk factors were smoking (92%),
arterial hypertension (39%), and dia-
betes mellitus (21%).
Patients who had already under-
gone surgical procedures in this vas-
cular segment were not included in the
study.
At the first visit, the extent of arte-
rial occlusion was determined by
physical examination (palpation of ar-
terial pulses) and confirmed by the AG
already performed. All patients had an
ankle/brachial index of less than 0.8,
assessed with a Doppler ultrasound us-
ing a Vascular Minilab model 1050-C
(Parks Medical Electronics, Inc -
Aloha, OR). Next, in order to objec-
tively assess the severity of IC, we
measured the maximum walking dis-
tance (MWD) on a progressive tread-
mill test using a motorized Trimline
Model 2200.1 treadmill (Hebb Indus-
tries, Inc - Whitehouse, TX). This was
done at a constant velocity of 3.2 km/
hr initially on the level (0 degrees) and
then with a progressive increase of 2%
in the inclination every 2 minutes. The
test was performed until pain pre-
vented the patient from continuing to
walk.
A program of physical activity,
consisting of walking for 40 minutes
per day, 4 times a week, was pre-
scribed. Patients were instructed to
continue to walk after the onset of
typical pain but before the pain
reached its maximum intensity. At this
point they were to rest until pain
abated and then start walking again to
complete the time required.
Patients were carefully instructed
in person by the authors regarding the
benefits of exercise training. Also, they
were encouraged to stop smoking and
instructed about the benefits of doing
so. No patient was given any type of
pharmacological therapy, such as
vasodilators or pentoxifylline, but
those who were using antiplatelet
therapy for cardiac diseases were in-
structed to continue it. Hypertension,
diabetes, and hyperlipidemia, when
present, were always treated by the
clinical physician.
Patients were reevaluated after 3
months, 6 months, and every 6 months
thereafter. Follow-up time ranged from
1 to 106 months, with an average of
39 months. At each visit, the treadmill
test was performed and the MWD de-
termined. The minimum time interval
between the first and last evaluations
was 6 months, except for 2 patients
who, within this period of time, pre-
sented with clinical deterioration ne-
cessitating a new arteriography for sur-
gical intervention.
At the last evaluation, in addition
to the clinical analysis and walking
test, a magnetic resonance angiogra-
phy was performed using a gadolinium
injection to determine whether there
was occlusion of the vessel studied.
The first and the last evaluations
were used for this study.
Regarding the analysis of the arte-
riography, the stenosis sites were iden-
tified as the common iliac artery (CIA)
or external iliac artery (EIA). The de-
gree of stenosis (<70% or >70%) was
obtained by dividing the arterial meas-
urement at the stenosis site by the av-
erage of the measurements made at lo-
cations immediately proximal and
distal to the stenosis.
Regarding the analysis of the
gadolinium magnetic resonance angi-
ography, whether there was occlusion
of the vessel studied or not was deter-
mined.
We defined 3 types of clinical evo-
lution based on the treadmill test, as
follows:
1. Improvement – an increase greater
than or equal to 20% of the initial
distance.
2. Stability – maintenance of the ini-
tial distance with a variation of up
to 20%.
3. Deterioration – reduction greater
than or equal to 20% of the initial
distance.
Compliance with treatment was de-
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termined based on patient reporting.
We considered patients to be compli-
ant with treatment when they kept
their risk factors under control and per-
formed the prescribed exercises.
The data were primarily analyzed
using the chi-square test or Fisher’s ex-
act test, depending on the number ob-
tained in each group. Statistical sig-
nificance was declared at the 5% (P
<.05) level. The primary factors that
could influence the progression of a
stenosis were analyzed, such as risk
factors (smoking, hypertension, diabe-
tes, sex, and age), compliance with
clinical treatment, initial degree of ste-
nosis, site of the stenosis, and length
of follow-up.
Afterwards, a logistic regression
test was performed using the following
variables: occlusion, site of occlusion,
degree of stenosis, compliance with
treatment, and clinical evolution.
RESULTS
The average length of follow-up
was 39 months and ranged from 1 to
106 months. There was no association
between occlusion and the length of
observation.
Regarding the distribution of ste-
nosis, 73% of the lesions were in the
common iliac artery (CIA) and 27%
were in the external iliac artery (EIA).
Regarding the extent of stenosis, 48%
were greater than or equal to 70% oc-
cluded.
There was no association between
the progression of the stenosis and the
risk factors (sex, smoking, hypertension,
and diabetes), as shown in Table 1.
There was an improvement in the
walking distances in 47% of the pa-
tients, 24% remained stable, and 29%
worsened with clinical treatment.
Twenty-five patients (66%) were con-
sidered compliant with the treatment.
Of these, 21 (84%) presented a clini-
cal course with an improvement or that
was unchanged, and 4 (16%) wors-
ened. This result was statistically sig-
nificant (P = .02).
There was an improvement in the
walking distances in 47% of the pa-
tients, 24% remained stable and 29%
worsened with clinical treatment.
Twenty-five patients (66%) were con-
sidered compliant with the treatment.
Of these, 21 (84%) presented a clini-
cal course with an improvement or that
was unchanged, and 4 (16%) wors-
ened. Thirteen patients (34%) were
considered non-compliant with the
treatment. Of these, 6 (46%) presented
with a clinical course with an improve-
ment or that was unchanged, and
7(64%) worsened. This result was sta-
tistically significant (p=0.02).
The clinical course of patients was
significantly related to the progression
of their stenosis to occlusion (Table 2).
Of the 52 lesions analyzed, 13 (25%)
evolved to occlusion. When an occlu-
sion occurred, there was clinical dete-
rioration in the majority of cases
(63.2%). This association was statisti-
cally significant (P = .002) when com-
pared to the cases that did not evolve
to occlusion.
Figure 1 shows a 69 year old pa-
tient with a patent iliac stenosis before
and after clinical treatment. In con-
trast, Figure 2 shows a 41 year old pa-
tient with a complete occlusion of a
previously stenotic artery.
There was no statistically signifi-
cant relationship between the progres-
sion of stenosis to occlusion and de-
gree of stenosis (P = .42), stenosis site
(P = .29), or compliance to treatment
(P = .74).
The average age of the patients
who evolved to occlusion was 57.4
years, while this age was 63.4 years for
patients who did not evolve to occlu-
sion. This result was statistically sig-
nificant (P = .02).
In the first logistic regression
model, utilizing clinical evolution as
the dependent variable, 2 factors were
shown to be determinants of clinical
deterioration: arterial occlusion and
noncompliance with treatment, as
shown in Table 3. The importance of
these factors is clear, as shown in Ta-
ble 3. If there was progression of a ste-
nosis to occlusion in a patient who did
not have adequate clinical treatment,
the probability of clinical deteriora-
Table 2 - Clinical course of patients in relation to the evolution of their stenosis.
 Clinical Course  
Evolution of the stenosis Improved or unchanged Deteriorated Total
Oclusion 0 4 0 9 13
Non-oclusion 34 0 5 39
Total 38 14 52
Table 1 - Relation between the risk factors and the progression of the stenosis.
Progression of Stenosis
Risk Factors Occlusion Non-Occlusion Total p
Male 10 20 30
Female 0 1 0 7 0 8 p> 0,05
Smoking 10 25 35
Non-Smoking 0 1 0 2 0 3 p> 0,05
Hypertension 0 3 12 15
Non-Hypertension 0 8 15 23 p> 0,05
Diabetes 0 1 0 7 0 8
Non-Diabetes 10 20 30 p> 0,05
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Figure 1a - Sixty nine year old man. Arteriography with critical stenosis in common iliac
arteries.
Figure 1b - Sixty months later, without occlusion and clinical improvement.
tion was 88.2%. On the other hand, if
there was no occlusion and the treat-
ment was adequate, this probability
fell to 5.2%.
In the second logistic regression
model, utilizing arterial occlusion as
the dependent variable, the only sta-
tistically significant association was
with clinical evolution. On the basis
of the observed results, it can be seen
that for a patient with stenosis of any
degree who presented with clinical
worsening, the probability that throm-
bosis of a vessel had occurred was
64.3%. If a patient showed clinical im-
provement or was stable, the probabil-
ity that the vessel had occluded was
10.5%.
DISCUSSION
Intermittent claudication of the
Iower Iimbs usually hinders the pa-
tient’s habitual activities, and the ob-
jective of treatment is to improve the
quality of life.18
Initial treatment is always con-
servative because IC has a good prog-
nosis. With conservative treatment,
most of the patients show improvement
or stability of the clinical manifesta-
tions5,19 with low risk of amputation. In
our service, the patients undergo con-
servative treatment for at least 6
months as follows: nonsupervised
physical exercises with 1 hour of daily
walking20 and control of the primary
atherosclerotic risk factors (smoking,
hypertension, diabetes, and
hyperlipidemia).
Surgical or endovascular treatment
is only indicated when clinical treat-
ment is not effective (critical ischemia
or limiting IC).21-23
Patients with IC and stenosis in the
iliac arteries form a group that poses
some problems for the vascular sur-
geon. Should the patient be followed
with only clinical treatment or should
the lesion be surgically treated before
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it can evolve to a thrombosis?
There are studies showing that
claudicating patients with stenosis
have a worse prognosis than do those
with total occlusion of the vessel, since
there is a greater risk of progression of
the lesion.24
The possibility of endovascular
treatment, which produces better re-
sults in stenosis than occlusions, em-
phasizes the importance of having a
better knowledge of these lesions.
When occlusion occurs, the proximal
and distal depositions of thrombi make
the endovascular treatment more dif-
ficult or even impossible.
The choice of diagnostic method is
one of the greatest challenges in study-
ing stenosis in the iliac arteries. Arte-
riography is considered the gold
standard for quantifying stenosis; how-
ever, arteriography is an invasive pro-
cedure that should not be requested
unless there is a convincing clinical
justification.16,25 Among the less inva-
sive methods, the duplex scan presents
some limitations in the iliac region
because of difficulties in viewing the
whole arterial segment and precisely
quantifying the stenosis in some situ-
ations.26 Magnetic resonance angiog-
raphy (MRA) is a relatively new
method that is being refined and very
probably will substitute for arteriogra-
phy in most cases. Although it is still
not very precise for quantifying steno-
sis,27,28 it offers security in the diagno-
sis of complete occlusions, which is
the reason why this method was cho-
sen.29 Both duplex scans and MRA
were used in this study because MRA
can only be used to determine whether
the vessel is occluded, and not to
measure the degree of occlusion.
Arteriography is not our routine
procedure for IC. However, the patients
included in this study were referred to
us from other hospital services that had
already performed the examination.
Thus, it was possible to perform this
clinical study making use of this impor-
Table 3 - Determinant factors for clinical deterioration.
Occlusion Treatment Probability of clinical deterioration
Present Non-compliant 88.2%
Present Compliant 53.0%
Absent Non-compliant 26.5%
Absent Compliant 05.2%
Figure 2a - Forty one year old man. Arteriography with critical stenosis in right common iliac
artery.
Figure 2b - Twenty nine months later, iliac occlusion with clinical deterioration.
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tant information—that is, the initial de-
gree of stenosis as revealed by AG. For
this reason, from among over 1300 pa-
tients presenting with IC, only 38 (those
having undergone preliminary AG)
were included in this study.
Clinical treatment produced a sat-
isfactory response, since 71% of the
patients maintained or increased their
walking distance. There was an asso-
ciation between clinical evolution and
compliance with treatment, showing
that patients who correctly followed
the guidance had a better prognosis,
which has already been reported in the
literature.30 However, there was no as-
sociation between compliance with
treatment and progression of the ste-
nosis, showing that clinical treatment
does not forestall arterial occlusion.
Walsch et al.,14 studying the natu-
ral evolution of stenosis in the super-
ficial femoral arteries, observed that
after an average period of 37 months,
there was no progression of the lesion
in 72% of the patients and that there
was a clear relationship between the
progress of the disease and clinical de-
terioration. In the iliac arteries, we ob-
served a similar result, since after an
average length of observation of 39
months, 25% of the stenosis pro-
gressed to occlusion, with the major-
ity of these patients (69.2%) demon-
strating clinical deterioration.
During the observation period, 5
patients in our series developed criti-
cal ischemia, 4 with occlusion of the
iliac artery and 1 with progression of
the lesion in the femoropopliteal re-
gion. All these patients underwent
conventional surgical revascula-
rization, with 2 of them undergoing
amputation of toes.
The absence of an association be-
tween occlusion and degree of steno-
sis (greater or less than 70%) indicates
that the evolution of a stenosis to a
thrombosis probably takes place be-
cause of a destabilization of the
atherosclerotic plaque and not because
of the gradual progression of the ste-
nosis. Another factor that reinforces
this hypothesis is the absence of a re-
lationship between occlusion and
length of observation. There were pa-
tients with critical stenosis (greater
than 70%) who were followed up for
more than 5 years without progression
of the lesion and who showed signifi-
cant clinical improvement, just as there
were patients with discrete stenosis
who, within less than 6 months, pre-
sented with arterial thrombosis and
critical ischemia.
The relationship between age and
clinical evolution appears to confirm
the fact, already cited in the literature,
that atherosclerotic disease is more ag-
gressive among younger individuals,31
which may perhaps justify earlier in-
tervention, especially among this
group of patients.32
The determinant factors for the
clinical deterioration of patients were
noncompliance with treatment and the
occlusion of the vessel. The benefits
of clinical treatment are already well
known, and advice about these ben-
efits should always be given. Nonethe-
less, such treatment does not prevent
vessel occlusion, and if this occurs,
deterioration may occur in more than
50% of patients.
Since our primary objective is to
avoid clinical deterioration, one im-
portant strategy would be to avoid the
progression of stenosis to occlusion.
This could eventually be achieved ei-
ther by early endovascular interven-
tion or with the development of drugs
that may stabilize the atherosclerotic
plaque.
RESUMO
FERRARI FB e col. Evolução natural
das estenoses nas artérias ilíacas em
pacientes com claudicação inter-
mitente submetidos a tratamento
clínico. Rev. Hosp. Clín. Fac. Med.
S. Paulo 59(6):341-348, 2004.
OBJETIVO: Apesar da longa ex-
periência com o tratamento da Claudi-
cação Intermitente, pouco se sabe so-
bre a evolução natural das estenoses
nas artérias ilíacas. Com o advento do
tratamento endovascular, esse conhe-
cimento tornou-se importante.
MÉTODOS: Foram avaliadas cin-
qüenta e duas estenoses, diagnos-
ticadas por arteriografia, em 38 paci-
entes com claudicação intermitente
acompanhados clinicamente. Após um
intervalo de tempo mínimo de 6 me-
ses, os pacientes foram submetidos a
uma angioressonância para determinar
se houve oclusão arterial.
Principais medidas de avaliação:
Foram avaliados os principais fatores
que poderiam influenciar a progressão
da estenose, como os fatores de risco
(tabagismo, hipertensão, diabete, sexo,
idade), a aderência ao tratamento
clínico,o grau de estenose inicial, sua
localização e o tempo de observação.
RESULTADOS: O período médio de
observação foi de 39 meses. Das 52 le-
sões analisadas, 13 (25%) evoluíram
para oclusão. Quando houve oclusão,
ocorreu piora clínica na maioria dos ca-
sos (63,2%), sendo esta associação esta-
tisticamente significante (p=0,002). O
grau de estenose inicial, sua localização,
a aderência ao tratamento e o tempo de
observação não apresentaram relação
com a progressão da lesão. Os pacientes
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que evoluíram para oclusão eram mais
jovens (p=0,02). Pelo teste de regressão
logística, os fatores determinantes da pi-
ora clínica foram a oclusão do vaso e a
não aderência ao tratamento clínico.
CONCLUSÕES: A progressão da
estenose para oclusão, que ocorre em
25% dos casos, gera piora clínica. O
tratamento clínico, apesar de importan-
te, não preveniu a oclusão arterial, que
poderá ser alcançada com o desenvol-
vimento de drogas que possam estabi-
lizar a placa aterosclerótica ou com in-
tervenções endovasculares precoces.
UNITERMOS: Claudicação inter-
mitente. Evolução natural. Ateros-
clerose. Artéria ilíaca. Estenoses.
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